| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1085 nt | 0.3760 | |
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1459 nt | 0.3687 | |
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1531 nt | 0.3703 | |
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1462 nt | 0.3700 | |
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1669 nt | 0.3853 | |
| GGAAGUGACGCGAGGCGUAGCGGAAGUUACUGCAGCCGCGGUGUUGUGC… | 1523 nt | 0.3710 |
This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last four amino acids of the carboxy-terminus have been cleaved off. Several pseudogenes have been reported for this gene. Alternate transcriptional splice variants encoding different isoforms have been characterized. [provided by RefSeq, Jul 2008]
A review of multi-omics studies for human biological age estimation identified the SUMO1 as an aging-associated transcriptome feature, where its expression was correlated with age in the Framingham Offspring cohort [Solovev et al. DOI:10.1016/j.mad.2019.111192].